Company Overview and News

 
Banks Scrambling for Hong Kong Deposits Push Rates as High as 3% - Bloomberg

2018-05-01 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

 
China Merchants Bank tightens rules for mainlanders opening Hong Kong accounts

2017-01-25 scmp
China Merchants Bank (CMB) will next week sharply tighten eligibility rules for mainlanders to open accounts at its Hong Kong branches, the latest move by Chinese lenders to curb capital outflows as Beijing steps up efforts to temper a slide in the yuan.

 
Mobile payment, P2P transfer services are gaining popularity in Hong Kong, says survey

2016-12-14 scmp
The Jetco survey found 76 per cent of respondents use mobile payments, while 43 per cent make peer-to-peer transfers

 
Chinese banks sail into uncharted waters as they expand globally

2016-10-03 scmp
Chinese banks are sailing into uncharted waters as they follow their wealthy corporate and retail clients abroad, though obstacles brought about by compliance investigations are unlikely to slow the momentum as mainland lenders buck the trend that has seen their foreign counterparts trim global operations, market observers said.

 
Hong Kong Life leverages combined resources of partners to compete with larger rivals

2016-09-23 scmp
Hong Kong Life, a joint venture life insurance company owned by five financial firms, is drawing particular takeover interest thanks to its business portfolio and bank branch network. Its corporate history can also illustrate how a group of smaller lenders can join hands to compete with bigger players.

 
Hong Kong banks told to improve their game when it comes to competing for China business

2016-09-20 scmp
Hong Kong’s banks have been told to up their game when it comes to conducting China-related business as the industry undergoes a painful contraction driven by the mainland’s economic slowdown.

 
China’s PBOC Injects 28-Day Funds for First Time Since February - Bloomberg

2016-09-13 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

1
Private Banking Listings

2016-07-05 scmp
Hans Hanegraaf, Country Executive Singapore & CEO Private Banking Asia & Middle East Ian Pollock, Regional Head of Private Banking International North Asia Angel Wu, Regional Head of Products & Solutions Asia & Middle East

 
Paying by smartphone? New fintech app from JETCO to facilitate small money transfers

2016-04-26 scmp
Hong Kong has a new app that allows users to transfer money to other individuals over smartphones -- something that could be useful when divvying up a meal expense, or paying for small transactions.

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

2018-05-21 - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...